News Headline Summary

FDA approves RAVICTI which is marketed by Hyperion Therapeutics (HPTX)

Reaction details (17:18)

- HPTX shares moved 4.73% to the upside in reaction; last trade at USD 16.13.
UPDATE: In the 2 mins following the news Co.'s shares were halted.

01 Feb 2013 - 17:16 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: